(1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride

Intermediate for Ticagrelor. Ticagrelor(trade name Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor. Ticagrelor is an antagonist of the P2Y12 receptor. Ticagrelor has been approved by US FDA in on July 20, 2011.

Specifications

Product Name:                  (1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride

Synonyms:                         N/A

CAS Number:                     156491-10-9

Molecular Weight:            205.6345

Molecular Formula:          C9H10ClF2N

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               FC1=C[C@@]([C@H]2[C@H](N)C2)=CC=C1F.Cl

(1R,2S)-rel-2-(3,4-Difluorophenyl)cyclopropanamine hydrochloride

  • $138.00
  • Ex Tax: $138.00

Available Options